S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4

Lignende værker

• Increased frequency of ICOS(+) CD4 T-cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy
  af: Tang, Derek Ng, et al.
  Udgivet: (2013)
• S43. Dendritic cell vaccination combined with CTLA4 blockade
  af: Thielemans, K, et al.
  Udgivet: (2014)
• Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
  af: Fan, Xiaozhou, et al.
  Udgivet: (2014)
• ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
  af: Soldevilla, Mario Martínez, et al.
  Udgivet: (2019)
• Combining anti-CTLA4 with RG7787, an immunotoxin targeting mesothelin, promotes tumor eradication
  af: Leshem, Jasmin, et al.
  Udgivet: (2015)